Companies · Other Health Care

Drconsulta Ltd.

GRAND CAYMAN · Other Health Care

Diligence memoA one-page analyst read on Drconsulta Ltd. — recommendation, valuation, rhythm, risks.
$140.1M
Total raised · real
5
Rounds
3.3×
Latest step-up
Top 3%
Sector rank · raised
Series C
Latest stage · inferred · Wed Sep 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Drconsulta Ltd. looks fair against its niche peers and is at-risk on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 1.28× the median modeled value of Series C Other Health Care companies in 2022–2024 (47 peers) — value vs value, same stage and era.
  • Within the normal band (128% of peer median) for its niche.
At-risk
  • Last raise 3.8 yr ago; this sector typically re-raises about every 14 months.
  • Past due for a raise versus sector cadence — watch for distress or a bridge.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Drconsulta Ltd. is one of 5376 Other Health Care companies tracked from GRAND CAYMAN. By capital raised it ranks among the largest (ahead of 98% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
22
Investors (latest)
2022-09-07
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$250M$500M$750M$1.0BSeries B · 2015-12-18 Raised $26M (real) Modeled valuation $574M (est)$26M$574MSeries B2015Series B · 2017-03-24 Raised $27M (real) Modeled valuation $597M (est)$27M$597MSeries B2017Series B · 2017-11-28 Raised $3.5M (real) Modeled valuation $78M (est)$3.5M$78MSeries B2017Series B · 2019-01-10 Raised $20M (real) Modeled valuation $432M (est)$20M$432MSeries B2019Series C · 2022-09-07 Raised $64M (real) Modeled valuation $837M (est)$64M$837MSeries C2022+$27M+$3.5M+$20M+$64MCumulative $140M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series B$25.9M · 2015
Series B extension$27.0M · 2017
Series B extension$3.5M · 2017
Series B extension$19.5M · 2019
Series C$64.2M · 2022

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series A — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 40%.

Modeled valuation trajectory
$836.7M
Base estimate est.
$233.4M
Conservative case
$1.6B
Upside case
$428.0M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ca $40M–$100M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Series B · modeled $573.8M · 2015-12-182015Series B · modeled $597.4M · 2017-03-24Series B · modeled $78.3M · 2017-11-28Series B · modeled $432.0M · 2019-01-10Series C · modeled $836.7M · 2022-09-072022
Model inputs · modeled:benchmark-stage-stepup-v1
15%
Dilution assumption
Implied ownership sold in the financing.
73%
Survival probability
55% low · 85% high
1.29×/yr
Annual markup
1.48×/yr upside case
3.8 yr
Elapsed time used
3.8 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
20 mo
Avg between rounds
$20.8M/yr
Capital velocity
10.5 yr
On record since
2015
First round
5
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 58× above median
This company$140.1M
Sector median$2.4M
Latest round — vs other Series C rounds in sector (real $, this stage) 1.4× above median
This company$64.2M
Sector median$45.9M
Modeled value — vs sector median (estimate, all stages) 38× above median
This company$836.7M
Sector median$22.1M

Raised more than 98% of sector peers (real $). Modeled value above 96% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series C) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #10 of 47.

This companyCohort peer
$100.0M$1.0B$10.0B$10.0M$100.0M$1.0BCapital raised (log)Gravie, Inc. · Series C Raised $160.7M · modeled $1.3B (est)EmpowerMe Holdings, LLC · Series C Raised $96.6M · modeled $1.3B (est)Color Holdings, L.P. · Series C Raised $90.9M · modeled $1.1B (est)RSR Senior Residences, LLC · Series C Raised $73.7M · modeled $1.1B (est)Gynesonics, Inc · Series C Raised $299.1M · modeled $1.0B (est)Hello Heart Inc. · Series C Raised $127.0M · modeled $1.0B (est)Beta Bionics, Inc · Series C Raised $277.5M · modeled $1.0B (est)BioDerm Holdings, LP · Series C Raised $130.9M · modeled $1.0B (est)Kindbody, Inc. · Series C Raised $95.6M · modeled $874.4M (est)Fountain Life, LLC · Series C Raised $103.9M · modeled $827.7M (est)TherapyMatch, Inc. · Series C Raised $100.0M · modeled $808.6M (est)Drconsulta Ltd. (this company) Raised $140.1M · modeled $836.7M (est)Drconsulta Ltd.
CompanyStageRaised · realValue · estvs peer med.
Gravie, Inc.Series C$160.7M$1.3B2.04×
EmpowerMe Holdings, LLCSeries C$96.6M$1.3B1.92×
Color Holdings, L.P.Series C$90.9M$1.1B1.75×
RSR Senior Residences, LLCSeries C$73.7M$1.1B1.71×
Gynesonics, IncSeries C$299.1M$1.0B1.58×
Hello Heart Inc.Series C$127.0M$1.0B1.54×
Beta Bionics, IncSeries C$277.5M$1.0B1.54×
BioDerm Holdings, LPSeries C$130.9M$1.0B1.53×
Kindbody, Inc.Series C$95.6M$874.4M1.33×
Drconsulta Ltd. this companySeries C$140.1M$836.7M1.28×
Fountain Life, LLCSeries C$103.9M$827.7M1.26×
TherapyMatch, Inc.Series C$100.0M$808.6M1.23×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series B$25.9M2015-12-18$143.9M$573.8M85%
Series B$27.0M2017-03-24$149.8M$597.4M90%
Series B$3.5M2017-11-28$19.6M$78.3M90%
Series B$19.5M2019-01-10$108.3M$432.0M90%
Series C$64.2M2022-09-07$428.0M$836.7M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series B$25.9M2015-12-18
    • First recorded raise — entered as Series B.
    • 12 investors on this round.
  2. Series B$27.0M2017-03-24
    • Raised 15 mo later, in step with the ~14 mo sector norm.
    • Round roughly the size of the prior one.
    • 21 investors on this round.
  3. Series B$3.5M2017-11-28
    • Raised 8 mo later, in step with the ~14 mo sector norm.
    • Round 7.6× smaller than the prior — bridge or down round.
    • 8 investors on this round.
  4. Series B$19.5M2019-01-10
    • Raised 13 mo later, in step with the ~14 mo sector norm.
    • Round 5.5× larger than the prior — scaling up.
    • Switched to Rule 506(c) (was Rule 506(b)).
    • 17 investors on this round.
  5. Series C$64.2M2022-09-07
    • Raised again after 44 mo — slower than the ~14 mo sector norm.
    • Round 3.3× larger than the prior — scaling up.
    • Switched to Rule 506(b) (was Rule 506(c)).
    • 22 investors on this round.
Intelligence
2024 ~Q2
Modeled next raise · ~20mo cadence
$192.6M
Modeled next size est.range $125.2M$308.2M
3.3×
Last step-up
$20.8M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Hernan Kazah7 other2019-01
Marcos Wilson Pereira2 other2022-09
Gabriella Antici1 other2019-01
Juan Carlos Moreno1 other2015-12
Pedro De Andrade Faria1 other2022-09
Guilherme Azevedo2019-01
Hernan Carlos Kazah2015-12
Juan Claudio Vergara2015-12
Juan Vergara2019-01
Luiz Claudio Nacimento2015-12
Luiz Claudio Nascimento2017-03
Luiz Nascimento2019-01
Marcos Carlos Pereira2017-03
Marcos Pereira2019-01
Renato Carlos Velloso2015-12
Renato Velloso2019-01
Renato Wilson Franco2022-09
Renato Wilson Velloso Dias Cardoso2022-09
Thomaz Srougi2015-12
Tom Carlos Patterson2017-03
Tom Patterson2019-01
Registry & provenance

Drconsulta Ltd. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1668172
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Somatus, Inc.Other Health CareSeries C$140.1M$1.1Bsame sector · same stage
BioIntelliSense, Inc.Other Health CareSeries C$140.0M$328.7Msame sector · same stage
Cardiomems IncOther Health CareSeries C$139.6M$1.4Bsame sector · same stage
Bigfoot Biomedical, Inc.Other Health CareSeries C$144.1M$1.3Bsame sector · same stage
Conventus Orthopaedics IncOther Health CareSeries C$144.2M$921.2Msame sector · same stage
SpyGlassPharma, Inc.Other Health CareSeries C$134.8M$484.8Msame sector · same stage
Rapid Micro Biosystems, Inc.Other Health CareSeries C$134.6M$1.4Bsame sector · same stage
Vertiflex, Inc.Other Health CareSeries C$134.1M$1.0Bsame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Dror Ortho-Design LtdOther Health CareSeed$40.2M85%
Verici DX plcOther Health CareSeed$58.2M84%
MediCall Inc.Other Health CarePre-Seed$7.3M84%
Dror Ortho-Design, Inc.Other Health CareSeries C$637.6M84%
EndoscopyMD Holdings, LLCOther Health CareSeries B$157.0M83%
BioPorto A/SOther Health CarePre-Seed$773K83%
PDC Holdings, LLCOther Health CareSeed$32.6M83%
SomniFix International LLCOther Health CarePre-Seed$13.3M82%
Frequently asked
How much funding has Drconsulta Ltd. raised?
Drconsulta Ltd. has raised approximately $140.1M in disclosed capital across 5 recorded financing rounds, aggregated from public filings.
What is Drconsulta Ltd.'s estimated valuation?
Provath's modeled valuation for Drconsulta Ltd. is approximately $836.7M (modeled range $233.4M–$1.6B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Drconsulta Ltd. at?
Drconsulta Ltd.'s latest modeled financing stage is Series C. Its most recent recorded round closed around Wed Sep 07.
What does Drconsulta Ltd. do and where is it based?
Drconsulta Ltd. operates in the Other Health Care sector, based in GRAND CAYMAN.
Explore related

See where Drconsulta Ltd. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Drconsulta Ltd., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.